New Journey Health Technology Group Co.,LTD (SHE:002219)
China · Delayed Price · Currency is CNY 2.090
+0.010 (0.48%)
Aug 3, 2026, 3:04 PM CST
SHE:002219 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 248.76 | 393.49 | 471.53 | 601 | 559.38 | 2,033 |
Trading Asset Securities | 2.8 | 2.86 | 6.56 | - | - | - |
Cash & Short-Term Investments | 251.56 | 396.35 | 478.09 | 601 | 559.38 | 2,033 |
Cash Growth | -40.21% | -17.10% | -20.45% | 7.44% | -72.49% | 1084.46% |
Accounts Receivable | 1,282 | 1,234 | 1,214 | 1,064 | 771.31 | 568.98 |
Other Receivables | 110.47 | 101.74 | 99.13 | 117.91 | 138.28 | 141.28 |
Receivables | 1,393 | 1,336 | 1,313 | 1,182 | 909.59 | 710.26 |
Inventory | 174.85 | 151.26 | 202.35 | 227.57 | 166.29 | 185.27 |
Other Current Assets | 29.63 | 24.76 | 31.44 | 38.88 | 164.62 | 95.15 |
Total Current Assets | 1,849 | 1,908 | 2,025 | 2,050 | 1,800 | 3,024 |
Property, Plant & Equipment | 2,922 | 2,943 | 2,862 | 2,717 | 2,471 | 2,309 |
Long-Term Investments | 6.01 | 6.01 | 6.12 | 6.87 | 5.9 | 6.11 |
Goodwill | 1,113 | 1,112 | 1,112 | 1,112 | 884.1 | 884.1 |
Other Intangible Assets | 395.57 | 398.48 | 405.91 | 420 | 265.6 | 271.34 |
Long-Term Deferred Tax Assets | 179.26 | 183.9 | 159.16 | 163.13 | 152.23 | 126.17 |
Long-Term Deferred Charges | 68.47 | 63.5 | 71.27 | 97 | 66.21 | 69.18 |
Other Long-Term Assets | 35.03 | 32.18 | 35.73 | 25 | 12.56 | 0.68 |
Total Assets | 6,568 | 6,647 | 6,677 | 6,591 | 5,657 | 6,690 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 1,474 | 1,498 | 1,544 | 1,517 | 1,163 | 1,000 |
Accrued Expenses | 119.31 | 156.26 | 158.61 | 153.7 | 162.4 | 310.5 |
Short-Term Debt | 929.24 | 1,257 | 1,148 | 1,261 | 589.32 | 1,510 |
Current Portion of Long-Term Debt | - | 136.82 | 185.31 | 137.48 | 116.32 | - |
Current Portion of Leases | - | 38.61 | 45.68 | 80.26 | 95.06 | 37.13 |
Current Income Taxes Payable | 23.32 | 18.42 | 2.53 | 13.9 | 31.37 | 31.18 |
Current Unearned Revenue | 5.44 | 6.78 | 8.36 | 5.18 | 3.09 | 5.65 |
Other Current Liabilities | 913.57 | 428.61 | 463.99 | 284.05 | 1,167 | 1,663 |
Total Current Liabilities | 3,464 | 3,541 | 3,556 | 3,452 | 3,327 | 4,558 |
Long-Term Debt | 433.08 | 397.28 | 494.89 | 722.24 | 410.49 | 279.96 |
Long-Term Leases | 50.97 | 74.8 | 97.94 | 203.06 | 76.63 | 125.84 |
Long-Term Unearned Revenue | 2.16 | 2.22 | 1.39 | 2.88 | 2.27 | 2.25 |
Long-Term Deferred Tax Liabilities | 44.27 | 48.14 | 43.52 | 32.7 | 55.48 | 49.39 |
Other Long-Term Liabilities | 542.26 | 572.42 | 444.47 | 5.05 | 19.56 | 88.33 |
Total Liabilities | 4,537 | 4,636 | 4,638 | 4,418 | 3,892 | 5,104 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 3,452 | 3,387 | 3,387 | 3,411 | 3,264 | 1,865 |
Additional Paid-In Capital | 1,564 | 1,538 | 1,598 | 1,937 | 1,422 | 2,807 |
Retained Earnings | -2,784 | -2,805 | -2,836 | -2,943 | -2,963 | -3,120 |
Treasury Stock | -258.85 | -166.95 | -166.95 | -284.39 | - | - |
Total Common Equity | 1,973 | 1,954 | 1,983 | 2,120 | 1,723 | 1,553 |
Minority Interest | 58.23 | 58.29 | 55.75 | 52.72 | 42.35 | 32.98 |
Shareholders' Equity | 2,031 | 2,012 | 2,039 | 2,173 | 1,766 | 1,586 |
Total Liabilities & Equity | 6,568 | 6,647 | 6,677 | 6,591 | 5,657 | 6,690 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,413 | 1,905 | 1,971 | 2,404 | 1,288 | 1,953 |
Net Cash (Debt) | -1,162 | -1,508 | -1,493 | -1,803 | -728.45 | 80.15 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.35 | -0.46 | -0.45 | -0.55 | -0.22 | 0.04 |
Filing Date Shares Outstanding | 3,411 | 3,044 | 2,904 | 3,411 | 3,264 | 1,865 |
Total Common Shares Outstanding | 3,411 | 3,044 | 2,904 | 3,411 | 3,264 | 1,865 |
Working Capital | -1,616 | -1,633 | -1,531 | -1,402 | -1,527 | -1,535 |
Book Value Per Share | 0.58 | 0.64 | 0.68 | 0.62 | 0.53 | 0.83 |
Tangible Book Value | 464.01 | 442.89 | 464.87 | 587.82 | 573.46 | 397.63 |
Tangible Book Value Per Share | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 | 0.21 |
Buildings | - | 1,923 | 1,909 | 1,859 | 1,800 | 1,444 |
Machinery | - | 1,575 | 1,539 | 1,501 | 1,263 | 1,299 |
Construction In Progress | - | 973.4 | 805.9 | 646.79 | 528.62 | 666.26 |